Filing Details
- Accession Number:
- 0001209191-23-006037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-01 20:02:22
- Reporting Period:
- 2023-01-30
- Accepted Time:
- 2023-02-01 20:02:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
860730 | Hca Healthcare Inc. | HCA | Services-General Medical & Surgical Hospitals, Nec (8062) | 273865930 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1957740 | M Timothy Mcmanus | One Park Plaza Nashville TN 37203 | Group President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-01-30 | 7,800 | $254.05 | 14,087 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-01-30 | 100 | $254.60 | 13,987 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Right | Acquisiton | 2023-01-30 | 17,051 | $0.00 | 17,051 | $253.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,051 | 2024-01-30 | 2033-01-30 | No | 4 | A | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.54 to $254.475, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024.